Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
M.D. Anderson Cancer Center
University of California, Irvine
Institute of Hematology & Blood Diseases Hospital, China
University of Southern California
City of Hope Medical Center
MPN Research Foundation
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
RWTH Aachen University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Icahn School of Medicine at Mount Sinai
IRCCS Azienda Ospedaliero-Universitaria di Bologna
M.D. Anderson Cancer Center
University Health Network, Toronto
University Hospital, Brest
Ottawa Hospital Research Institute
Fox Chase Cancer Center
Federico II University
Queen's University, Belfast
University of Utah
University of Nebraska
University Health Network, Toronto
Herlev Hospital
The University of Hong Kong
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital, Bordeaux
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University Hospital, Geneva
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
University Hospital, Bordeaux
Fred Hutchinson Cancer Center
Mayo Clinic
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Mayo Clinic
University of Utah
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai